PT1076055E - Derivados de 1-[ (1-substituido-4-piperidinil)-metil]-4-piperidina, processo para a sua preparacao, composicoes medicinais que os contem e intermediarios destes compostos - Google Patents
Derivados de 1-[ (1-substituido-4-piperidinil)-metil]-4-piperidina, processo para a sua preparacao, composicoes medicinais que os contem e intermediarios destes compostosInfo
- Publication number
- PT1076055E PT1076055E PT99913701T PT99913701T PT1076055E PT 1076055 E PT1076055 E PT 1076055E PT 99913701 T PT99913701 T PT 99913701T PT 99913701 T PT99913701 T PT 99913701T PT 1076055 E PT1076055 E PT 1076055E
- Authority
- PT
- Portugal
- Prior art keywords
- piperidinyl
- intermediates
- substituted
- methyl
- preparing
- Prior art date
Links
- -1 1-SUBSTITUTED-4-PIPERIDINYL Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13450498 | 1998-04-28 | ||
| JP19501998 | 1998-06-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1076055E true PT1076055E (pt) | 2005-02-28 |
Family
ID=26468607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99913701T PT1076055E (pt) | 1998-04-28 | 1999-04-19 | Derivados de 1-[ (1-substituido-4-piperidinil)-metil]-4-piperidina, processo para a sua preparacao, composicoes medicinais que os contem e intermediarios destes compostos |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6294555B1 (pt) |
| EP (1) | EP1076055B1 (pt) |
| KR (1) | KR20010043032A (pt) |
| CN (1) | CN1118452C (pt) |
| AR (1) | AR019115A1 (pt) |
| AT (1) | ATE283260T1 (pt) |
| AU (1) | AU746406B2 (pt) |
| BR (1) | BR9909991A (pt) |
| CA (1) | CA2330475A1 (pt) |
| DE (1) | DE69922186T2 (pt) |
| ES (1) | ES2234248T3 (pt) |
| HK (1) | HK1031869A1 (pt) |
| HU (1) | HUP0101511A3 (pt) |
| ID (1) | ID26399A (pt) |
| IL (1) | IL138568A0 (pt) |
| NO (1) | NO318451B1 (pt) |
| NZ (1) | NZ507119A (pt) |
| PL (1) | PL343726A1 (pt) |
| PT (1) | PT1076055E (pt) |
| RU (1) | RU2214400C2 (pt) |
| SK (1) | SK15852000A3 (pt) |
| TW (1) | TWI242004B (pt) |
| WO (1) | WO1999055674A1 (pt) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6344358B1 (en) * | 1999-05-28 | 2002-02-05 | Fujisawa Pharmaceutical Co., Ltd. | Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
| NZ530202A (en) | 2001-07-02 | 2005-06-24 | Astrazeneca Ab | Piperidine derivatives useful as modulators of chemokine receptor activity |
| GB0120461D0 (en) | 2001-08-22 | 2001-10-17 | Astrazeneca Ab | Novel compounds |
| GB0122503D0 (en) | 2001-09-18 | 2001-11-07 | Astrazeneca Ab | Chemical compounds |
| SE0200844D0 (sv) | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
| SE0200843D0 (sv) | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
| US6696468B2 (en) | 2002-05-16 | 2004-02-24 | Dainippon Pharmaceutical Co., Ltd. | (s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor |
| SE0202838D0 (sv) * | 2002-09-24 | 2002-09-24 | Astrazeneca Ab | Chemical compounds |
| SE0300957D0 (sv) | 2003-04-01 | 2003-04-01 | Astrazeneca Ab | Chemical compounds |
| TW200533348A (en) * | 2004-02-18 | 2005-10-16 | Theravance Inc | Indazole-carboxamide compounds as 5-ht4 receptor agonists |
| WO2005092882A1 (en) * | 2004-03-01 | 2005-10-06 | Pfizer Japan, Inc. | 4-amino-5-halogeno-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, cns, neurological and cardiovascular disorders |
| TWI351282B (en) | 2004-04-07 | 2011-11-01 | Theravance Inc | Quinolinone-carboxamide compounds as 5-ht4 recepto |
| US7728006B2 (en) * | 2004-04-07 | 2010-06-01 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
| US8309575B2 (en) | 2004-04-07 | 2012-11-13 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
| US20050267141A1 (en) * | 2004-05-28 | 2005-12-01 | Phytogen Life Sciences Inc. | Process to prepare camptothecin derivatives |
| US7396933B2 (en) * | 2004-11-05 | 2008-07-08 | Theravance, Inc. | Quinolinone-carboxamide compounds |
| EP1807422B1 (en) * | 2004-11-05 | 2009-09-02 | Theravance, Inc. | 5-ht4 receptor agonist compounds |
| ATE469897T1 (de) * | 2004-12-22 | 2010-06-15 | Theravance Inc | Indazolcarbonsäureamidverbindungen |
| BRPI0608392A2 (pt) * | 2005-03-02 | 2009-12-29 | Theravance Inc | compostos de quinolinona como agonistas do receptor 5-ht4 |
| US7256294B2 (en) * | 2005-05-25 | 2007-08-14 | Theravance, Inc. | Crystalline form of a benzimidazole-carboxamide medicinal compound |
| MY147756A (en) | 2005-05-25 | 2013-01-15 | Theravance Inc | Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
| US8314127B2 (en) | 2005-07-21 | 2012-11-20 | Astrazeneca Ab | Piperidine derivatives |
| TWI423967B (zh) * | 2008-02-21 | 2014-01-21 | Dainippon Sumitomo Pharma Co | 醯胺衍生物及含有其之醫藥組合物 |
| US8642772B2 (en) | 2008-10-14 | 2014-02-04 | Sk Biopharmaceuticals Co., Ltd. | Piperidine compounds, pharmaceutical composition comprising the same and its use |
| US8232315B2 (en) | 2009-06-26 | 2012-07-31 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating drug addiction and improving addiction-related behavior |
| JP5836280B2 (ja) | 2009-11-06 | 2015-12-24 | エスケー バイオファーマスティカルズ カンパニー リミテッド | 注意欠陥／多動性障害（ａｄｈｄ）の治療方法 |
| JP5901528B2 (ja) | 2009-11-06 | 2016-04-13 | エスケー バイオファーマスティカルズ カンパニー リミテッド | 線維筋痛症候群の治療方法 |
| US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
| US8623913B2 (en) | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
| DK2780015T3 (en) * | 2011-11-18 | 2017-03-27 | Heptares Therapeutics Ltd | M1 MUSCARINRECEPTORAGONISTER |
| EP3413891B1 (en) * | 2016-02-11 | 2024-01-03 | Symed Labs Limited | Processes for the preparation of highly pure prucalopride succinate |
| GB201617454D0 (en) | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
| GB201819960D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| CN110950843B (zh) * | 2019-11-28 | 2022-12-27 | 广东东阳光药业有限公司 | 取代的苯酰胺衍生物及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9005014D0 (en) | 1990-03-06 | 1990-05-02 | Janssen Pharmaceutica Nv | N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives |
| GB9204565D0 (en) | 1992-03-03 | 1992-04-15 | Smithkline Beecham Plc | Pharmaceuticals |
| US5864039A (en) | 1994-03-30 | 1999-01-26 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzoic acid compounds and use thereof as medicaments |
| WO1996033973A1 (fr) * | 1995-04-28 | 1996-10-31 | Banyu Pharmaceutical Co., Ltd. | Derives disubstitues en position 1,4 de piperidine |
| JPH111472A (ja) * | 1996-04-30 | 1999-01-06 | Dainippon Pharmaceut Co Ltd | ベンズアミド誘導体及びそれを含有する医薬組成物 |
-
1999
- 1999-04-19 US US09/674,162 patent/US6294555B1/en not_active Expired - Fee Related
- 1999-04-19 WO PCT/JP1999/002056 patent/WO1999055674A1/ja not_active Application Discontinuation
- 1999-04-19 EP EP99913701A patent/EP1076055B1/en not_active Expired - Lifetime
- 1999-04-19 BR BR9909991-8A patent/BR9909991A/pt not_active IP Right Cessation
- 1999-04-19 AU AU31716/99A patent/AU746406B2/en not_active Ceased
- 1999-04-19 HU HU0101511A patent/HUP0101511A3/hu unknown
- 1999-04-19 NZ NZ507119A patent/NZ507119A/xx unknown
- 1999-04-19 CN CN99805583A patent/CN1118452C/zh not_active Expired - Fee Related
- 1999-04-19 AT AT99913701T patent/ATE283260T1/de not_active IP Right Cessation
- 1999-04-19 DE DE69922186T patent/DE69922186T2/de not_active Expired - Fee Related
- 1999-04-19 SK SK1585-2000A patent/SK15852000A3/sk unknown
- 1999-04-19 KR KR1020007011894A patent/KR20010043032A/ko not_active Application Discontinuation
- 1999-04-19 TW TW088106200A patent/TWI242004B/zh active
- 1999-04-19 PL PL99343726A patent/PL343726A1/xx unknown
- 1999-04-19 IL IL13856899A patent/IL138568A0/xx unknown
- 1999-04-19 ES ES99913701T patent/ES2234248T3/es not_active Expired - Lifetime
- 1999-04-19 CA CA002330475A patent/CA2330475A1/en not_active Abandoned
- 1999-04-19 PT PT99913701T patent/PT1076055E/pt unknown
- 1999-04-19 ID IDW20002107A patent/ID26399A/id unknown
- 1999-04-19 RU RU2000129161/04A patent/RU2214400C2/ru not_active IP Right Cessation
- 1999-04-28 AR ARP990101966A patent/AR019115A1/es unknown
-
2000
- 2000-10-27 NO NO20005430A patent/NO318451B1/no unknown
-
2001
- 2001-03-28 HK HK01102252A patent/HK1031869A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE283260T1 (de) | 2004-12-15 |
| DE69922186T2 (de) | 2005-05-04 |
| HUP0101511A3 (en) | 2002-12-28 |
| AR019115A1 (es) | 2001-12-26 |
| AU3171699A (en) | 1999-11-16 |
| US6294555B1 (en) | 2001-09-25 |
| NO20005430D0 (no) | 2000-10-27 |
| SK15852000A3 (sk) | 2001-06-11 |
| ID26399A (id) | 2000-12-21 |
| PL343726A1 (en) | 2001-09-10 |
| IL138568A0 (en) | 2001-10-31 |
| WO1999055674A1 (fr) | 1999-11-04 |
| CN1118452C (zh) | 2003-08-20 |
| RU2214400C2 (ru) | 2003-10-20 |
| ES2234248T3 (es) | 2005-06-16 |
| NO318451B1 (no) | 2005-03-21 |
| EP1076055A1 (en) | 2001-02-14 |
| HUP0101511A2 (hu) | 2001-09-28 |
| EP1076055B1 (en) | 2004-11-24 |
| BR9909991A (pt) | 2000-12-26 |
| AU746406B2 (en) | 2002-05-02 |
| EP1076055A4 (en) | 2001-07-18 |
| TWI242004B (en) | 2005-10-21 |
| DE69922186D1 (de) | 2004-12-30 |
| HK1031869A1 (en) | 2001-06-29 |
| NZ507119A (en) | 2002-08-28 |
| NO20005430L (no) | 2000-12-20 |
| KR20010043032A (ko) | 2001-05-25 |
| CA2330475A1 (en) | 1999-11-04 |
| CN1298391A (zh) | 2001-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1076055E (pt) | Derivados de 1-[ (1-substituido-4-piperidinil)-metil]-4-piperidina, processo para a sua preparacao, composicoes medicinais que os contem e intermediarios destes compostos | |
| PT1150961E (pt) | Derivados do acido pirazolecarboxilico processo para a sua preparacao e as composicoes farmaceuticas que os contem | |
| PT885204E (pt) | Novos derivados de arilglicinamida, processo para a sua preparacao e composicoes farmaceuticas que contem estes compostos | |
| PT1192122E (pt) | Derivados de benzeno processo para a sua preparacao e composicoes farmaceuticas que os contem | |
| PT1202965E (pt) | Derivados de indol processos para a sua preparacao composicoes farmaceuticas que os contem e a sua aplicacao | |
| PT1339675E (pt) | Compostos bisarilo orto, meta-substituidos, processo para a sua preparacao, sua utilizacao como medicamentos e composicoes farmaceuticas que os contem | |
| BR9707839A (pt) | Primido-Ú5,4-D¾-primidas medicamentos contendo esses compostos sua aplicação e processo para a sua preparação | |
| PT97899A (pt) | Processo para a preparacao de novos derivados de imidazol e de composicoes farmaceuticas que os contem | |
| BR9609701A (pt) | Composição farmacéutica composto e processo para a preparação de compostos | |
| BR9810829B1 (pt) | composto heterocìclico, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica. | |
| PT99671A (pt) | Processo para a preparacao de heparosanos-n,o-sulfatados e de composicoes farmaceuticas que os contem | |
| AR018609A1 (es) | Composicion farmaceutica solida estabilizada que contiene un derivado de acido 4-amino-3-sustituido-butanoico y proceso para su preparacion. | |
| PT918759E (pt) | Novos derivados de tiazolidino-2,4-diona substituidos processos para a sua obtencao e as composicoes farmaceuticas que os contem | |
| BR8803133A (pt) | Compostos heterociclicos nitro-substituidos,processo para sua preparacao,composicoes inseticidas,processo para combater insetos,aplicacao e processo para a preparacao de composicoes | |
| PT1049721E (pt) | Polissacaridos de sintese processo para a sua preparacao e composicoes farmaceuticas que os contem | |
| BR9506106A (pt) | Composto processo para sua preparação medicamento e composição farmacêutica | |
| BR9711340A (pt) | Composto composi-Æo farmac-utica e processo para preparar um composto | |
| PT1122254E (pt) | Derivados de 4-sulfonamidas piperidina, processo para a sua preparacao e as composicoes farmaceuticas que os contem | |
| EE04311B1 (et) | Asoolid, nende valmistamismeetod, kasutamine ravimina ja farmatseutiline kompositsioon | |
| BR1100524A (pt) | Compostos, processo para sua preparação; compostos intermediários para os mesmos, e composições farmacêuticas | |
| PT92649A (pt) | Processo para a preparacao do 4-fluoro-2-< { (4-metoxi-2-piridinil)-metil}-sulfinil>-1h-benzimidazol e de composicoes farmaceuticas que o contem | |
| PT1118610E (pt) | Novos derivados de benzeno-sulfonamida processo para a sua preparacao e as composicoes farmaceuticas que os contem | |
| PT842927E (pt) | 3-AMIDO-CROMANILSULFONIL(TIO)-UREIAS PROCESSOS PARA A SUA PREPARACAO SUA UTILIZACAO E COMPOSICOES FARMACêUTICAS QUE AS CONTEM | |
| PT1395582E (pt) | Novos derivados de piperidinocarboxamida, metodo para a sua preparacao e composicoes farmaceuticas que os contem | |
| PT1165528E (pt) | Novos derivados de morfolina, processo para a sua preparacao e composicoes farmaceuticas que os contem |